Inovalon Holdings, Inc. (INOV) Analysts See $0.10 EPS

October 17, 2018 - By Hugh Holland

Inovalon Holdings, Inc. (NASDAQ:INOV) Logo

Analysts expect Inovalon Holdings, Inc. (NASDAQ:INOV) to report $0.10 EPS on November, 7.They anticipate $0.03 EPS change or 42.86 % from last quarter’s $0.07 EPS. INOV’s profit would be $15.27M giving it 26.63 P/E if the $0.10 EPS is correct. After having $0.12 EPS previously, Inovalon Holdings, Inc.’s analysts see -16.67 % EPS growth. The stock increased 1.43% or $0.15 during the last trading session, reaching $10.65. About 71,952 shares traded. Inovalon Holdings, Inc. (NASDAQ:INOV) has declined 38.30% since October 17, 2017 and is downtrending. It has underperformed by 53.92% the S&P500.

Inovalon Holdings, Inc., a technology company, provides cloud platforms empowering a data-driven transformation from volume to value models throughout the healthcare industry. The company has market cap of $1.63 billion. The firm through, large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and industry-leading subject matter expertise, enables the assessment and improvement of clinical and quality outcomes, and financial performance across the healthcare ecosystem. It currently has negative earnings. It serves health plans and well-known provider organizations, as well as pharmaceutical, medical device, and diagnostics companies.

More recent Inovalon Holdings, Inc. (NASDAQ:INOV) news were published by: Seekingalpha.com which released: “Inovalon Got It All To Show” on September 23, 2018. Also Nasdaq.com published the news titled: “Report: Exploring Fundamental Drivers Behind Inovalon, Evolent Health, Limoneira, Overstock, Hologic, and Reading …” on October 17, 2018. Nasdaq.com‘s news article titled: “ABILITY Network Announces the 2018 HomeCare Elite” with publication date: October 08, 2018 was also an interesting one.

Inovalon Holdings, Inc. (NASDAQ:INOV) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>